Simulations Plus, Inc. SLP reported fourth-quarter fiscal 2025 adjusted earnings of 10 cents per share, matching the Zacks Consensus Estimate. The bottom line, however, compared unfavorably with the ...

As of Tuesday, December 02, Simulations Plus, Inc.’s SLP share price has surged by 14.14%, which has investors questioning if ...

Simulations Plus' silico software boosts non-animal drug development and drives growth. Read here for an investment analysis ...

Boeing Co (NYSE: BA) rose 8.4% to $202.15 after the company reportedly said that it expects a year-over-year increase in its ...

RESEARCH TRIANGLE PARK, N.C. (AP) — RESEARCH TRIANGLE PARK, N.C. (AP) — Simulations Plus Inc. (SLP) on Monday reported a loss of $681,000 in its fiscal fourth quarter. The Research Triangle Park, ...

Return on Assets (ROA): Simulations Plus's ROA is below industry standards, pointing towards difficulties in efficiently ...

Simulations Plus, Inc. SLP recently rolled out the StrategiesPlus COVID-19 ACT Program to aid researchers in their fight against the global coronavirus pandemic. Offerings of the integrated program ...

The CEO highlighted industry momentum, noting that "the momentum behind biosimulation continues to accelerate," and emphasized that Simulations Plus is investing in AI and cloud computing to build an ...

RESEARCH TRIANGLE PARK, N.C. - Simulations Plus, Inc. (NASDAQ:SLP) shares jumped 5.2% after the biosimulation company reported fourth quarter earnings that met analyst expectations and reaffirmed its ...

A “Validated” column in the DDI perpetrator table to clearly identify the values that have been validated by our DDI experts for use in simulations Dr. Michael Bolger, Founding Scientist of Simulation ...

Polen Capital Management, a value-driven, concentrated, long-term investment management firm, published its ‘Polen U.S. Small Company Growth’ fourth-quarter 2020 Investor Letter – a copy of which can ...